Recent Updates
Recently added Catalysts
ELAN Negative Sentiment Score: 20/100

Elanco Animal Health Incorporated Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – ELAN

Key Takeaway: Elanco Animal Health Incorporated is facing a securities law class action lawsuit due to alleged misleading public statements about its products, specifically Zenrelia and Credelio Quattro. The allegations suggest that Elanco misrepresented the safety of Zenrelia and failed to meet its projected timeline for U.S. approval and launch of its products. Shareholders who purchased shares during the specified class period are encouraged to contact The Gross Law Firm for potential involvement in the class action. The deadline to register for lead plaintiff status is December 6, 2024.

Market Sentiment Analysis

CONCERNS & RISKS

  • Elanco faced allegations of issuing materially false statements regarding Zenrelia's safety.
  • The company is unlikely to meet the approval timeline for Zenrelia and Credelio Quattro.
  • Financial prospects of Elanco were overstated, impacting investor trust.

Full Press Release Details

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Elanco Animal Health Incorporated (NYSE: ELAN).
Shareholders who purchased shares of ELAN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: November 7, 2023 to June 26, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Zenrelia, a once-daily oral inhibitor for canine dermatology, was less safe than the Company had led investors to believe; (ii) Elanco was unlikely to meet its own previously issued timeline for the U.S. approval and commercial launch of both Zenrelia and Credelio Quattro, a broad spectrum parasiticide product for dogs; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
DEADLINE: December 6, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/elanco-animal-health-incorporated-loss-submission-form/?id=114500&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ELAN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is December 6, 2024. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
15 West 38th Street, 12th floor
Phone: (646) 453-8903

Tags

Frequently Asked Questions

What is the class period for Elanco Animal Health shareholders?

The class period for shareholders is from November 7, 2023, to June 26, 2024.

What allegations are made against Elanco Animal Health?

The allegations include false statements and safety concerns about Zenrelia and delays in product launches.

How can shareholders participate in the class action?

Shareholders can register through a provided link to enroll in the class action.

When is the deadline to become a lead plaintiff?

The deadline to seek lead plaintiff status is December 6, 2024.

Is there a cost to participate in the case?

There is no cost or obligation for shareholders to participate in the case.

Last updated: Dec 4, 2024